PACS Group (NYSE:PACS) Price Target Raised to $44.00

PACS Group (NYSE:PACS) had its target price upped by UBS Group from $42.00 to $44.00 in a research report report published on Wednesday,Benzinga reports. They currently have a buy rating on the stock.

A number of other equities analysts have also issued reports on the company. Weiss Ratings reissued a “hold (c-)” rating on shares of PACS Group in a report on Monday, December 22nd. Royal Bank Of Canada boosted their price target on PACS Group from $47.00 to $52.00 and gave the stock an “outperform” rating in a research report on Friday, February 27th. Wall Street Zen raised PACS Group from a “hold” rating to a “buy” rating in a research note on Sunday, February 15th. Zacks Research raised PACS Group from a “strong sell” rating to a “hold” rating in a report on Friday, January 30th. Finally, JPMorgan Chase & Co. initiated coverage on shares of PACS Group in a research note on Wednesday, December 17th. They set an “overweight” rating and a $44.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $44.40.

PACS Group Price Performance

Shares of NYSE:PACS opened at $34.30 on Wednesday. The firm’s 50 day moving average is $38.05 and its two-hundred day moving average is $25.12. The firm has a market capitalization of $5.39 billion, a P/E ratio of 27.89, a PEG ratio of 1.14 and a beta of -0.64. The company has a current ratio of 1.07, a quick ratio of 0.94 and a debt-to-equity ratio of 0.36. PACS Group has a 52 week low of $7.50 and a 52 week high of $43.08.

Institutional Trading of PACS Group

Several institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in PACS Group by 14.4% during the 4th quarter. Vanguard Group Inc. now owns 4,506,227 shares of the company’s stock worth $172,994,000 after buying an additional 566,502 shares during the period. Alyeska Investment Group L.P. boosted its holdings in shares of PACS Group by 159.5% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,250,007 shares of the company’s stock worth $86,378,000 after buying an additional 1,382,984 shares during the period. Crewe Advisors LLC boosted its holdings in shares of PACS Group by 93.1% in the fourth quarter. Crewe Advisors LLC now owns 2,147,815 shares of the company’s stock worth $82,455,000 after buying an additional 1,035,747 shares during the period. Royce & Associates LP increased its position in shares of PACS Group by 76.6% in the third quarter. Royce & Associates LP now owns 1,859,070 shares of the company’s stock worth $25,525,000 after acquiring an additional 806,446 shares in the last quarter. Finally, Balyasny Asset Management L.P. increased its position in shares of PACS Group by 67.3% in the third quarter. Balyasny Asset Management L.P. now owns 1,356,240 shares of the company’s stock worth $18,621,000 after acquiring an additional 545,348 shares in the last quarter.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.